Medline Industries, LP recalled 596 medical convenience kits on July 25, 2025. The recall affects kits with Flexicare BritePro Solo Fiber Optic Laryngoscope Handles due to light failure. Patients and healthcare providers must stop using these devices immediately.
Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Flexicare BritePro Solo Fiber Optic Laryngoscope Handles due to the failure of the light to illuminate as intended.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact MEDLINE INDUSTRIES, LP - Northfield or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recall includes the following kits: 1. Newborn Resuscitation Kit, Kit Number ACC010381C; 2. Drawer 5 - Position 3, Kit Number ACC010532; 3. Drawer #4C Adult, Kit Number ACC010671; 4. Drawer #2, Kit Number ACC010728. These kits were distributed in Alabama, California, Delaware, Oregon, Tennessee, and Texas.
The recalled kits contain laryngoscope handles that may fail to illuminate. This failure could hinder critical medical procedures requiring proper visualization.
No injuries or incidents related to this issue have been reported so far. The recall is classified as Class I, indicating a high risk.
Patients and healthcare providers should stop using the recalled kits immediately. Contact Medline Industries, LP or your healthcare provider for detailed instructions on the recall.
For more information, contact Medline Industries, LP at their Northfield location or visit their website.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.